This section collates various resources to help improve clinical practice in the management of harms resulting from the use of club drugs and novel psychoactive substances.
This is an extensive and comprehensive reference aimed at clinicians and other practitioners across a range of clinical settings.
This paper describes patterns of club drug use among LGBT populations, as reported in the literature. It examines the factors that may impact on the use of substances and discusses drug-related and other harms.
This paper looks at Synthetic cannabinoid receptor agonists (SCRAs), a large group of drugs which have a strong effect on the endocannabinoid system.
This paper looks at the misuse of synthetic opioids: harms and clinical management of fentanyl, fentanyl analogues and other novel synthetic opioids – Information for clinicians.
